Improving Outcomes After Relapse in Ewing's Sarcoma: Analysis of 114 Patients From a Single Institution
The outcome for patients with relapsed Ewing's sarcoma is poor. A retrospective analysis was carried out to identify factors associated with improved survival. Between 1992 and 2002, 114 patients presented with relapsed or progressive disease. Median time to progression/relapse was 13 months (r...
Main Authors: | Anne M. McTiernan, Anna M. Cassoni, Deirdre Driver, Maria P. Michelagnoli, Anne M. Kilby, Jeremy S. Whelan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2006-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/SRCM/2006/83548 |
Similar Items
-
A Phase II Study of Docetaxel in Patients with Relapsed and Refractory Ewing's Tumours
by: T. Meyer, et al.
Published: (2003-01-01) -
A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma
by: Anne McTiernan, et al.
Published: (2006-01-01) -
Outcomes of Adult Ewing Sarcoma Treated with Multimodality Therapy: A Single-Institute Experience
by: Ravi Chandran, et al.
Published: (2020-10-01) -
Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience
by: Kurt R. Weiss, et al.
Published: (2011-01-01) -
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis
by: Thomas J. Carter, et al.
Published: (2020-11-01)